Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy-Reference-Cited by-同舟云学术

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

Published:2011-01-12 Issue:1 Volume:9 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Neubauer Horst,Kaiser Andreas FC,Endres Heinz G,Krüger Jan C,Engelhardt Andreas,Lask Sebastian,Pepinghege Fenena,Kusber Andreas,Mügge Andreas

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1741-7015-9-3.pdf

Reference39 articles.

1. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988, 2: 349-360.

2. Farid NA, Kurihara A, Wrighton SA: Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol. 2010, 50: 126-142. 10.1177/0091270009343005.

3. Mehta SR, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators: The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J. 2000, 21: 2033-2041. 10.1053/euhj.2000.2474.

4. Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, Zembala M, Opolski G, Huber K, Arnesen H, Kristensen SD, De Caterina R: Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2009, 30: 426-435. 10.1093/eurheartj/ehn562.

5. Patrono C, Baigent C, Hirsh J, Roth G, American College of Chest Physicians: Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008, 133: 199S-233S. 10.1378/chest.08-0672.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance;Molecular Diagnosis & Therapy;2024-01-23

2. Antiplatelet Resistance in Patients Who Underwent Coronary Artery Bypass Grafting: A Systematic Review and Meta-Analysis;The American Journal of Cardiology;2023-11

3. Monitoring the Antiplatelet Therapy Efficacy in Patients with Acute Ischemic Stroke;CLIN LAB;2023

4. Verifynow P2Y12 PRU-Guided Modification of Clopidogrel for Prevention of Recurrent Ischemic Stroke: A Real-World Prospective Cohort Study;Neurology and Therapy;2022-09-26

5. Long-Term Durability and Recurrence Patterns After Endovascular Treatment for Basilar Tip Aneurysms;World Neurosurgery;2022-07